Published in J Pediatr on December 01, 1999
Toxoplasma gondii: from animals to humans. Int J Parasitol (2000) 10.45
Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev (2012) 4.07
Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model. PLoS Negl Trop Dis (2011) 1.09
Prevalence of congenital Toxoplasma gondii infection among newborns from the Poznań region of Poland: validation of a new combined enzyme immunoassay for Toxoplasma gondii-specific immunoglobulin A and immunoglobulin M antibodies. J Clin Microbiol (2001) 1.02
Newborn screening for congenital toxoplasmosis: feasible, but benefits are not established. Arch Dis Child (2006) 1.01
Neglected parasitic infections in the United States: toxoplasmosis. Am J Trop Med Hyg (2014) 0.96
Novel interpretation of molecular diagnosis of congenital toxoplasmosis according to gestational age at the time of maternal infection. J Clin Microbiol (2012) 0.93
Delayed maturation of IgG avidity in congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis (2004) 0.90
Evaluation of a commercial IgG/IgM Western blot assay for early postnatal diagnosis of congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis (2003) 0.90
A meta analysis on risks of adverse pregnancy outcomes in Toxoplasma gondii infection. PLoS One (2014) 0.84
Assessment of laboratory methods used in the diagnosis of congenital toxoplasmosis after maternal treatment with spiramycin in pregnancy. BMC Infect Dis (2014) 0.81
Clinical value of specific immunoglobulin E detection by enzyme-linked immunosorbent assay in cases of acquired and congenital toxoplasmosis. J Clin Microbiol (2003) 0.80
Cerebellar toxoplasmosis in HIV/AIDS infant: case report and review of the literature. Neurol Sci (2012) 0.78
Evaluation of the liaison automated testing system for diagnosis of congenital toxoplasmosis. Clin Vaccine Immunol (2012) 0.77
Laboratory Diagnosis of Congenital Toxoplasmosis. J Clin Microbiol (2016) 0.75
Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies. Sex Transm Infect (2002) 4.14
Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis (1989) 3.67
Low male partner participation in antenatal HIV counselling and testing in northern Tanzania: implications for preventive programs. AIDS Care (2008) 3.58
Raised serum levels of tumour necrosis factor in parasitic infections. Lancet (1986) 3.23
Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet (1999) 2.97
Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group . Lancet (1999) 2.54
Toxoplasmosis needs evaluation. An overview and proposals. Am J Dis Child (1989) 2.49
Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis. Eur J Clin Microbiol Infect Dis (1996) 2.43
Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. J Clin Microbiol (1997) 2.22
Uterine rupture after previous caesarean section. BJOG (2010) 2.18
Malaria chemoprophylaxis: why mefloquine? Lancet (1990) 2.13
The Thucydides syndrome. A new hypothesis for the cause of the plague of Athens. N Engl J Med (1985) 2.04
Risk factors for Toxoplasma gondii infection in pregnancy. Results of a prospective case-control study in Norway. Am J Epidemiol (1996) 2.04
Prevalence and risk factors of severe obstetric haemorrhage. BJOG (2008) 1.97
Recombinant antigens to detect Toxoplasma gondii-specific immunoglobulin G and immunoglobulin M in human sera by enzyme immunoassay. J Clin Microbiol (2000) 1.92
Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol (1999) 1.92
CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut (2003) 1.87
MRI-guided STN DBS in Parkinson's disease without microelectrode recording: efficacy and safety. J Neurol Neurosurg Psychiatry (2010) 1.84
Paternal age effect in Down's syndrome. Ann Hum Genet (1977) 1.84
Economic evaluation of maternal screening to prevent congenital syphilis. Sex Transm Dis (1984) 1.83
Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. Pediatrics (2001) 1.80
A novel immunoassay using recombinant allergens simplifies peanut allergy diagnosis. Int Arch Allergy Immunol (2010) 1.80
Dissection of the human antibody response to the malaria antigen Pf155/RESA into epitope specific components. Immunol Rev (1989) 1.73
Incidence study of Down's syndrome in Copenhagen, 1960-1971; with chromosome investigation. Ann Hum Genet (1976) 1.72
Acyclovir in late pregnancy to prevent neonatal herpes simplex. Lancet (1990) 1.71
Primary structure and localization of a conserved immunogenic Plasmodium falciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate life cycle. Mol Biochem Parasitol (1991) 1.70
Risk factors for sudden intrauterine unexplained death: epidemiologic characteristics of singleton cases in Oslo, Norway, 1986-1995. Am J Obstet Gynecol (2001) 1.69
Acceptance, reliability and confidence of diagnosis of fetal and neonatal virtuopsy compared with conventional autopsy: a prospective study. Ultrasound Obstet Gynecol (2012) 1.68
Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators. J Am Coll Cardiol (1997) 1.67
Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines. Bone Marrow Transplant (2001) 1.66
Risk factors of HIV vertical transmission in a cohort of women under a PMTCT program at three peri-urban clinics in a resource-poor setting. J Perinatol (2010) 1.64
Detection of IgA specific for toxoplasmosis in serum and cerebrospinal fluid using a non-enzymatic IgA-capture assay. Diagn Immunol (1986) 1.60
The past and present role of the Sabin-Feldman dye test in the serodiagnosis of toxoplasmosis. Bull World Health Organ (1999) 1.56
Severe toxoplasmosis caused by a Toxoplasma gondii strain with a new isoenzyme type acquired in French Guyana. J Clin Microbiol (1998) 1.55
Serotypes of Ureaplasma urealyticum isolated from normal pregnant women and patients with pregnancy complications. J Clin Microbiol (1988) 1.54
Real-time PCR for detection and quantitation of hepatitis B virus DNA. J Med Virol (2001) 1.52
Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G. J Pediatr (2000) 1.51
Variations in policies for management of the third stage of labour and the immediate management of postpartum haemorrhage in Europe. BJOG (2007) 1.51
The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999-2002. Arch Dis Child (2006) 1.49
Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol (1984) 1.47
Dynamic sonography with provocation of pain for diagnosis of symptomatic mobile kidneys. Eur J Surg (2001) 1.46
Hydroxyl radical generation in oxygen-treated infants. Pediatrics (1997) 1.46
Factors predicting interferon treatment response in patients with chronic hepatitis c: late viral clearance does not preclude a sustained response. Am J Gastroenterol (2001) 1.46
The cytogenetic basis for classifying ependymomas. J Neuropathol Exp Neurol (1978) 1.44
Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol (2001) 1.44
Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease. Neurology (2010) 1.44
Quantitative bacterial examination of domestic water supplies in the Lesotho Highlands: water quality, sanitation, and village health. Bull World Health Organ (1999) 1.43
A systematic review of the prevalence of Chlamydia trachomatis among European women. Hum Reprod Update (2002) 1.43
Comparative epidemiology of sudden infant death syndrome and sudden intrauterine unexplained death. Arch Dis Child Fetal Neonatal Ed (2002) 1.43
Rotavirus genotypes co-circulating in Europe between 2006 and 2009 as determined by EuroRotaNet, a pan-European collaborative strain surveillance network. Epidemiol Infect (2010) 1.42
Recombinant Toxoplasma gondii surface antigen 1 (P30) expressed in Escherichia coli is recognized by human Toxoplasma-specific immunoglobulin M (IgM) and IgG antibodies. Clin Diagn Lab Immunol (1996) 1.41
Human parvoviruses B19, PARV4 and bocavirus in pediatric patients with allogeneic hematopoietic SCT. Bone Marrow Transplant (2013) 1.41
Preoperative ECMO in congenital cyanotic heart disease using the AREC system. Ann Thorac Surg (1997) 1.41
Bilateral papillitis in ocular toxoplasmosis. Eye (Lond) (2009) 1.39
Type of delivery onset has a significant impact on post-natal mortality in preterm infants of less than 30 weeks' gestation. Acta Paediatr (2014) 1.38
Usefulness of Toxoplasma gondii-specific recombinant antigens in serodiagnosis of human toxoplasmosis. J Clin Microbiol (2004) 1.37
Early neonatal diagnosis of congenital toxoplasmosis: value of comparative enzyme-linked immunofiltration assay immunological profiles and anti-Toxoplasma gondii immunoglobulin M (IgM) or IgA immunocapture and implications for postnatal therapeutic strategies. J Clin Microbiol (1996) 1.35
Real-time PCR targeting a 529-bp repeat element for diagnosis of toxoplasmosis. Clin Microbiol Infect (2006) 1.33
An enzyme-linked immuno-filtration assay used to compare infant and maternal antibody profiles in toxoplasmosis. J Immunol Methods (1985) 1.31
Antibodies to a recombinant glutamate-rich Plasmodium falciparum protein: evidence for protection of individuals living in a holoendemic area of Liberia. Am J Trop Med Hyg (1992) 1.29
Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis Suppl (1992) 1.28
Recombinant Plasmodium falciparum glutamate rich protein; purification and use in enzyme-linked immunosorbent assay. Am J Trop Med Hyg (1991) 1.28
Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Eur J Clin Microbiol Infect Dis (2001) 1.26
Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene. Infect Immun (1999) 1.26
HIV seroprevalence and its associations with the other reproductive tract infections in asymptomatic women in Harare, Zimbabwe. Int J STD AIDS (2001) 1.26
Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy. Sex Transm Infect (1999) 1.24
Ultrasensitive bioanalytical assays using time-resolved fluorescence detection. Pharmacol Ther (1995) 1.24
Provocative appeals in anti-smoking mass media campaigns targeting adolescents--the accumulated effect of multiple exposures. Health Educ Res (1997) 1.24
Eosinophilic differentiation of the human promyelocytic leukemia cell line, HL-60. J Exp Med (1984) 1.22
Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation. Br Heart J (1995) 1.21
Performance of European laboratories testing serum samples for Toxoplasma gondii. Eur J Clin Microbiol Infect Dis (1996) 1.20
Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group. Scand J Infect Dis (1998) 1.19
Risk factors for parvovirus B19 infection in pregnancy. JAMA (1999) 1.19
An anti-human mu chain monoclonal antibody: use for detection of IgM antibodies to Toxoplasma gondii by reverse immunosorbent assay. J Immunol Methods (1985) 1.18
Realities and Challenges of a Five Year Follow Up of Mother and Child Pairs on a PMTCT Program in Zimbabwe. Open AIDS J (2011) 1.18
Visual and somatosensory evoked cortical potentials in multiple sclerosis. J Neurol Neurosurg Psychiatry (1979) 1.16
Induction of a protective antibody-dependent response against toxoplasmosis by in vitro excreted/secreted antigens from tachyzoites of Toxoplasma gondii. Parasite Immunol (1988) 1.15
Outcome of children after maternal primary Toxoplasma infection during pregnancy with emphasis on avidity of specific IgG. The Study Group. Pediatr Infect Dis J (1995) 1.15
The program for antenatal screening of toxoplasmosis in Finland: a prospective cohort study. Scand J Infect Dis Suppl (1992) 1.13
Toxoplasmosis in pregnancy. Baillieres Clin Obstet Gynaecol (1993) 1.13
Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1. Allergy (2006) 1.12